Free Stock & ETF Comparisons

Compare Duke Energy and Southern Company by nuclear fleet exposure, renewable energy capex, Vogtle cost recovery, dividend yield, and regulated rate base growth.

Compare NextEra Energy and PG&E by renewable energy pipeline, regulated safety record, wildfire liability risk, rate case outcomes, and analyst upside.

Compare GE Aerospace and Honeywell by aviation engine cycle exposure, defense backlog, industrial automation revenue, operating margins, and valuation.

Compare GE Aerospace and Boeing by commercial engine installed base, defense program backlog, production recovery, operating margins, and analyst upside.

Compare Boeing and Embraer by commercial aircraft delivery pipeline, defense revenue, regional jet vs widebody mix, and long-term aviation demand exposure.

Compare Cummins and PACCAR by engine electrification exposure, trucking cycle sensitivity, international sales mix, dividend yield, and long-term value.

Compare Caterpillar and Cummins by construction and mining cycle exposure, services revenue growth, international diversification, margins, and dividend yield.

Compare Stanley Black & Decker and Martin Marietta Materials by infrastructure spending exposure, margin recovery, pricing power, dividend track record, and analyst upside.

Compare Stanley Black & Decker and Snap-on by professional tool franchise value, industrial distribution model, margin recovery, dividend track record, and analyst upside.

Compare Rockwell Automation and Honeywell by factory automation adoption, industrial software revenue, process control market share, margins, and long-term value.

Compare United Rentals and Herc Holdings by fleet utilisation, specialty rental revenue, construction and industrial customer mix, operating margins, and analyst upside.

Compare Ecolab and Air Products by water treatment revenue, hydrogen infrastructure investment, pricing power, return on capital, and long-term valuation.

Compare Eastman Chemical and CF Industries by end-market diversification, nitrogen price cycle leverage, specialty vs commodity chemical mix, and analyst upside.

Compare PPG Industries and Axalta Coating Systems by architectural vs automotive coatings mix, pricing power, EV vehicle refinish demand, operating margins, and analyst upside.

Compare CBRE Group and Jones Lang LaSalle by transaction advisory revenue, property management recurring income, capital markets exposure, and real estate cycle value.

Compare Johnson & Johnson and Merck by drug pipeline depth, oncology revenue, medical device strength, dividend growth, and long-term shareholder value.

Compare Pfizer and Merck by drug pipeline, oncology and vaccine revenue, post-COVID recovery, dividend sustainability, and analyst upside.

Compare Johnson & Johnson and GSK by vaccine portfolio, oncology pipeline, MedTech vs consumer health strategy, dividend growth, and valuation.

Compare Pfizer and AstraZeneca by oncology pipeline strength, rare disease growth, mRNA platform potential, international market presence, and analyst upside.

Compare Bristol-Myers Squibb and AstraZeneca by cancer drug revenue, immune-oncology pipeline, blood thinner competition, international growth, and valuation.

Compare Eli Lilly and Regeneron by GLP-1 obesity drug revenue, Dupixent vs Mounjaro growth trajectory, pipeline breadth, operating margins, and analyst upside.

Compare AbbVie and Amgen by immunology drug revenue, biosimilar exposure, post-Humira pipeline strength, dividend yield, and long-term valuation.

Compare Gilead Sciences and Regeneron by HIV franchise durability, oncology pipeline, Dupixent vs Lenacapavir revenue momentum, margins, and analyst upside.

Compare Amgen and Gilead Sciences by biosimilar defense, HIV franchise durability, obesity drug pipeline, dividend yield, and long-term value.

Compare Amgen and Biogen by biosimilar competition, pipeline depth, Alzheimer's drug momentum, obesity drug ambitions, dividend yield, and valuation.

Compare Vertex Pharmaceuticals and Biogen by cystic fibrosis monopoly, Alzheimer's drug momentum, rare disease pipeline, margins, and analyst upside.

Compare Repligen and Alnylam by bioprocessing revenue recovery, RNA interference drug pipeline, clinical breadth, operating margins, and analyst upside.

Compare Edwards Lifesciences and Boston Scientific by TAVR adoption, electrophysiology revenue, structural heart pipeline, operating margins, and analyst upside.

Compare Edwards Lifesciences and Medtronic by structural heart market share, pacemaker and CGM revenue, international device growth, margins, and analyst upside.

Compare Abbott Laboratories and Zimmer Biomet by CGM market growth, orthopedic implant volumes, robotic surgery pipeline, margins, and analyst upside.

Compare Becton Dickinson and Thermo Fisher by diagnostics and biosciences growth, recurring revenue mix, margins, acquisition strategy, and long-term value.

Compare Becton Dickinson and Johnson & Johnson by diagnostics revenue, MedTech breadth, drug pipeline vs device growth, dividend history, and valuation.

Compare Cigna and Humana by Medicare Advantage enrollment, pharmacy benefit management, medical loss ratio, revenue growth, and analyst upside.

Compare JPMorgan Chase and Citigroup by ROE differential, wealth management revenue, international banking footprint, capital ratio, and transformation progress.

Compare Goldman Sachs and Citigroup by trading revenue, investment banking cycle exposure, wealth management growth, capital return potential, and analyst upside.

Compare American Express and Mastercard by premium cardholder spending, cross-border transaction volume, network economics, operating margins, and analyst upside.

Compare AIG and MetLife by combined ratio improvement, group benefits revenue, international life insurance exposure, capital return potential, and analyst upside.

Compare Allstate and Progressive by combined ratio, telematics pricing advantage, premium growth, underwriting margins, and analyst upside.

Compare Chubb and Travelers by commercial lines pricing power, catastrophe exposure, combined ratio, premium growth, dividend yield, and analyst upside.

Compare BNY Mellon and State Street by assets under custody, fee revenue growth, investment services income, dividend track record, and long-term valuation.

Compare Aflac and Unum Group by Japan supplemental insurance market, employer-paid benefits revenue, earnings stability, dividend consistency, and valuation.

Compare Capital One and Synchrony Financial by credit card delinquency trends, net interest margin, retail partnership revenue, digital banking growth, and analyst upside.

Compare Discover Financial and Capital One by network transaction volume, credit quality, merger dynamics, net interest income, and long-term value.

Compare Kraft Heinz and Mondelez by organic revenue growth, international snacking portfolio, brand reinvestment, margin profile, and dividend sustainability.

Compare General Mills and Campbell Soup by volume trends, pet food growth, snacking vs meals portfolio shift, pricing power, and long-term shareholder value.

Compare Constellation Brands and AB InBev by premium beer revenue growth, wine divestiture impact, emerging market exposure, dividend yield, and valuation.

Compare Kimberly-Clark and Procter & Gamble by tissue and hygiene market share, emerging market penetration, dividend growth history, and long-term value.

Compare Hormel Foods and Tyson Foods by packaged food premiumization, protein cycle exposure, operating margins, and dividend track record.